BF
AZN icon

BOK Financial’s AstraZeneca AZN Stock Holding History

BOK Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,123
Closed -$4.23M – 1380
2024
Q2 		$4.23M Buy
27,123
+14,318
+112% +$2.15M 0.08% 221
2024
Q1 		$1.72M Sell
12,805
-52,095
-80% -$6.9M 0.03% 395
2023
Q4 		$8.74M Sell
64,900
-3,391
-5% -$441K 0.17% 133
2023
Q3 		$8.64M Sell
68,291
-2,289
-3% -$313K 0.19% 121
2023
Q2 		$10.1M Sell
70,580
-915
-1% -$135K 0.21% 111
2023
Q1 		$9.92M Sell
71,495
-5,545
-7% -$746K 0.21% 110
2022
Q4 		$10.4M Sell
77,040
-65,445
-46% -$8.21M 0.19% 115
2022
Q3 		$15.6M Sell
142,485
-2,887
-2% -$366K 0.32% 77
2022
Q2 		$19.2M Buy
145,372
+8,426
+6% +$1.11M 0.37% 66
2022
Q1 		$18.2M Buy
136,946
+57,616
+73% +$6.91M 0.3% 78
2021
Q4 		$9.24M Buy
79,330
+1,653
+2% +$195K 0.14% 155
2021
Q3 		$9.33M Buy
+77,677
New +$9.04M 0.16% 137
2021
Q1 		$6.89M Buy
69,241
+2,513
+4% +$253K 0.13% 170
2020
Q4 		$6.67M Sell
66,728
-14,363
-18% -$1.52M 0.13% 167
2020
Q3 		$8.89M Buy
81,091
+407
+0.5% +$45.3K 0.2% 115
2020
Q2 		$8.54M Buy
80,684
+3,701
+5% +$382K 0.2% 114
2020
Q1 		$6.88M Buy
76,983
+9,455
+14% +$890K 0.2% 118
2019
Q4 		$6.73M Sell
67,528
-6,866
-9% -$646K 0.15% 152
2019
Q3 		$6.63M Buy
74,394
+11,066
+17% +$959K 0.16% 147
2019
Q2 		$5.23M Buy
63,328
+7,361
+13% +$577K 0.13% 188
2019
Q1 		$4.53M Sell
55,967
-2,718
-5% -$214K 0.11% 210
2018
Q4 		$4.46M Buy
58,685
+494
+0.8% +$38.6K 0.13% 182
2018
Q3 		$4.61M Sell
58,191
-699
-1% -$52.9K 0.12% 209
2018
Q2 		$4.14M Sell
58,890
-4,373
-7% -$315K 0.11% 222
2018
Q1 		$4.42M Buy
63,263
+14,247
+29% +$987K 0.13% 191
2017
Q4 		$3.4M Buy
49,016
+8,905
+22% +$601K 0.09% 253
2017
Q3 		$2.72M Buy
40,111
+9,499
+31% +$600K 0.08% 276
2017
Q2 		$2.09M Buy
30,612
+2,194
+8% +$143K 0.07% 306
2017
Q1 		$1.77M Buy
28,418
+7,081
+33% +$412K 0.06% 348
2016
Q4 		$1.17M Buy
21,337
+158
+0.7% +$8.97K 0.04% 430
2016
Q3 		$1.39M Buy
21,179
+8,985
+74% +$587K 0.05% 401
2016
Q2 		$737K Buy
12,194
+91
+0.8% +$5.29K 0.03% 505
2016
Q1 		$682K Sell
12,103
-82
-0.7% -$4.93K 0.02% 505
2015
Q4 		$828K Buy
12,185
+156
+1% +$10.2K 0.03% 466
2015
Q3 		$766K Buy
12,029
+700
+6% +$46.1K 0.03% 473
2015
Q2 		$722K Sell
11,329
-58
-0.5% -$3.97K 0.02% 517
2015
Q1 		$779K Buy
11,387
+3,126
+38% +$217K 0.03% 478
2014
Q4 		$581K Sell
8,261
-2,579
-24% -$185K 0.02% 476
2014
Q3 		$774K Buy
10,840
+115
+1% +$8.42K 0.03% 483
2014
Q2 		$797K Sell
10,725
-13,442
-56% -$972K 0.03% 500
2014
Q1 		$1.57M Sell
24,167
-2,062
-8% -$133K 0.05% 356
2013
Q4 		$1.56M Sell
26,229
-617
-2% -$33.5K 0.05% 344
2013
Q3 		$1.4M Sell
26,846
-15,454
-37% -$776K 0.05% 353
2013
Q2 		$2M Buy
+42,300
New +$2.15M 0.08% 262

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BOK Financial's AZN Position: Q3 2024 in Review

BOK Financial sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 27,123 shares — an estimated $4.23M sold.

BOK Financial first reported a position in AZN in Q2 2013 and held it in 44 quarters. The position peaked at $19.2M in Q2 2022. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • BOK Financial reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
  • BOK Financial sold 27,123 AstraZeneca shares in Q3 2024, an estimated $4.23M.
  • BOK Financial first reported a position in AstraZeneca in Q2 2013 and held it in 44 quarters.
  • BOK Financial's AstraZeneca position peaked at $19.2M in Q2 2022.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on BOK Financial's 13F filing for Q3 2024, filed 14 Nov 2024.